Literature DB >> 16570307

Polymorphism on leflunomide: stability and crystal structures.

Daniel Vega1, Alicia Petragalli, Daniel Fernández, Javier A Ellena.   

Abstract

Two polymorphs of Leflunomide were found and studied (form I and II). Both of them were characterized by X-ray powder diffraction and thermal analysis. Single crystals were obtained and both structures were solved. Forms I and II crystallize in the space group P2(1)/c with two and one independent molecules per asymmetric unit, respectively. Thermodynamic stability of the two forms is assessed by differential scanning calorimetry. The cohesion in the crystal of form I (the more stable) is provided by both by H bonding as well as pi...pi interactions, while in form II it is given only by the former. The independent molecules in form I adopt different conformations thus allowing for a larger number of intermolecular interactions. (c) 2006 Wiley-Liss, Inc. and the American Pharmacists Association

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16570307     DOI: 10.1002/jps.20382

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  3 in total

1.  New insights and innovation from a million crystal structures in the Cambridge Structural Database.

Authors:  Jason C Cole; Seth Wiggin; Francesca Stanzione
Journal:  Struct Dyn       Date:  2019-08-28       Impact factor: 2.920

2.  Leflunomide Loaded Chitosan Nanoparticles for the Preparation of Aliphatic Polyester Based Skin Patches.

Authors:  Stavroula G Nanaki; Sophia Andrianidou; Panagiotis Barmpalexis; Evi Christodoulou; Dimitrios N Bikiaris
Journal:  Polymers (Basel)       Date:  2021-05-11       Impact factor: 4.329

3.  Poly ε-Caprolactone Nanoparticles for Sustained Intra-Articular Immune Modulation in Adjuvant-Induced Arthritis Rodent Model.

Authors:  Ekta Singh; Riyaz Ali M Osmani; Rinti Banerjee; Amr Selim Abu Lila; Afrasim Moin; Khaled Almansour; Hany H Arab; Hadil Faris Alotaibi; El-Sayed Khafagy
Journal:  Pharmaceutics       Date:  2022-02-26       Impact factor: 6.321

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.